JPWO2023078604A5 - - Google Patents
Info
- Publication number
- JPWO2023078604A5 JPWO2023078604A5 JP2024526529A JP2024526529A JPWO2023078604A5 JP WO2023078604 A5 JPWO2023078604 A5 JP WO2023078604A5 JP 2024526529 A JP2024526529 A JP 2024526529A JP 2024526529 A JP2024526529 A JP 2024526529A JP WO2023078604 A5 JPWO2023078604 A5 JP WO2023078604A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- disorder
- compound
- formula
- salt
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163276117P | 2021-11-05 | 2021-11-05 | |
| US63/276,117 | 2021-11-05 | ||
| EPPCT/EP2022/056991 | 2022-03-17 | ||
| PCT/EP2022/056991 WO2022195011A1 (en) | 2021-03-18 | 2022-03-17 | Psilocybin analogs, salts, compositions, and methods of use |
| PCT/EP2022/076073 WO2023078604A1 (en) | 2021-11-05 | 2022-09-20 | Formulations of psilocybin analogs and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540282A JP2024540282A (ja) | 2024-10-31 |
| JP2024540282A5 JP2024540282A5 (https=) | 2025-09-25 |
| JPWO2023078604A5 true JPWO2023078604A5 (https=) | 2025-09-25 |
Family
ID=83558221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526529A Pending JP2024540282A (ja) | 2021-11-05 | 2022-09-20 | シロシビン類似体の製剤および使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250213527A1 (https=) |
| EP (1) | EP4426675A1 (https=) |
| JP (1) | JP2024540282A (https=) |
| KR (1) | KR20240095294A (https=) |
| CN (1) | CN117177959A (https=) |
| AU (1) | AU2022381220B2 (https=) |
| CA (1) | CA3236624A1 (https=) |
| IL (1) | IL312175A (https=) |
| WO (1) | WO2023078604A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021268204A1 (en) | 2020-05-08 | 2022-12-08 | Psilera Inc. | Novel compositions of matter and pharmaceutical compositions |
| IL308816A (en) | 2021-05-25 | 2024-01-01 | Atai Therapeutics Inc | New n,n-dimethyltryptamine salts and crystalline salt forms |
| WO2023018864A1 (en) | 2021-08-12 | 2023-02-16 | Psilosterics, Llc | Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same |
| JP2024545787A (ja) | 2021-12-30 | 2024-12-11 | アタイ セラピューティクス， インコーポレイテッド | 一酸化窒素送達剤としてのジメチルトリプタミン類似体 |
| CA3247344A1 (en) * | 2022-06-09 | 2023-12-14 | Diamond Therapeutics Inc. | AMORPHIC PSILOCYBIN (A-POLYMORPHIC) |
| US12049447B2 (en) | 2022-06-30 | 2024-07-30 | Zylorion Health Inc. | Crystalline forms of compositions comprising psilocin and psilocybin |
| AU2023343417B2 (en) * | 2022-09-12 | 2026-02-19 | Tryp Therapeutics, Inc | Psilocin crystalline forms |
| WO2024180030A1 (en) | 2023-02-27 | 2024-09-06 | Cybin Irl Limited | Methods of treating depressive disorders with a psilocybin analog |
| WO2025019800A1 (en) * | 2023-07-19 | 2025-01-23 | Atai Therapeutics, Inc. | Novel prodrugs and conjugates of dimethyltryptamine and methods of using the same |
| US12280068B1 (en) | 2023-11-09 | 2025-04-22 | Zylorion Health Inc. | Uses of a co-crystal of psilocybin and psilocin |
| US20250302075A1 (en) * | 2024-04-01 | 2025-10-02 | Tsi Group Co., Ltd. | Compositions and methods of preparation of a clear, effervescent delivery form for nutritional ingredients |
| US20260021070A1 (en) * | 2024-07-19 | 2026-01-22 | Compass Pathfinder Limited | Subcutaneous formulations comprising psilocybin derivatives |
| CN119610304A (zh) * | 2024-12-10 | 2025-03-14 | 澳创新耐火材料(中山)有限公司 | 一种低值植物纤维材料重组防火门芯及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| US5798119A (en) | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
| PH12022551981A1 (en) * | 2020-02-04 | 2023-10-16 | Mindset Pharma Inc | Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disorders |
| US11312684B1 (en) | 2021-02-10 | 2022-04-26 | Eleusis Therapeutics Us, Inc. | Pharmaceutically acceptable salts of psilocin and uses thereof |
| WO2022195011A1 (en) * | 2021-03-18 | 2022-09-22 | Cybin Irl Limited | Psilocybin analogs, salts, compositions, and methods of use |
-
2022
- 2022-03-17 CN CN202280022029.2A patent/CN117177959A/zh active Pending
- 2022-09-20 CA CA3236624A patent/CA3236624A1/en active Pending
- 2022-09-20 US US18/707,825 patent/US20250213527A1/en active Pending
- 2022-09-20 AU AU2022381220A patent/AU2022381220B2/en active Active
- 2022-09-20 EP EP22783493.4A patent/EP4426675A1/en active Pending
- 2022-09-20 JP JP2024526529A patent/JP2024540282A/ja active Pending
- 2022-09-20 WO PCT/EP2022/076073 patent/WO2023078604A1/en not_active Ceased
- 2022-09-20 KR KR1020247017594A patent/KR20240095294A/ko active Pending
- 2022-09-20 IL IL312175A patent/IL312175A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023078604A5 (https=) | ||
| JP4597532B2 (ja) | Ｎ−［フェニル（ピペリジン−２−イル）メチル］ベンズアミド誘導体類、それらの製造方法および治療におけるそれらの使用 | |
| RU2194048C2 (ru) | Производные пиперазина, способ их получения и фармацевтическая композиция | |
| CN1189170C (zh) | 噻吩基唑基烷氧基乙胺,它们的制备以及它们作为药物的应用 | |
| US9453027B2 (en) | Deuterium-enriched pyridinonecarboxamides and derivatives | |
| JP6195605B2 (ja) | 薬学的活性剤の製造方法 | |
| JP2011523658A (ja) | アルホルモテロールの合成方法 | |
| JP2009526821A (ja) | 注意欠陥多動性障害治療用の新規な医薬組成物 | |
| KR20060094079A (ko) | Ｎ-[페닐(피페리딘-2-일)메틸]벤즈아미드의 유도체, 그의제조 방법 및 치료법에서의 그의 용도 | |
| TW201002682A (en) | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine | |
| EA023293B1 (ru) | ЛИГАНДЫ НЕЙРОНАЛЬНОГО НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА αβ | |
| JP5739415B2 (ja) | （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用 | |
| JP2002508364A (ja) | セロトニン１ａ受容体に対して活性を有するアリールピペラジン | |
| TW201028428A (en) | Process for producing diamine derivatives | |
| RU2011123890A (ru) | Кристаллическая форма 4-[2-(2-фторфеноксиметил)фенил]пиперидинового соединения | |
| JP2016510768A (ja) | 抗不安化合物の塩、共結晶及び多形 | |
| JPWO2023036473A5 (https=) | ||
| EP3875151B1 (en) | Alpha-methyl-substituted diazabicyclo [4.3.1] decane derivates for treatment of psychiatric disorders | |
| JP2012512145A5 (https=) | ||
| JPH08509212A (ja) | ４−アリールイソインドール鎮痛薬 | |
| JPWO2022195011A5 (https=) | ||
| CN1260791A (zh) | 3－苄基哌啶类化合物 | |
| KR20010108381A (ko) | 신규 모르폴린 유도체, 그의 제조 방법 및 그를 함유하는제약 제제 | |
| WO2005000305A1 (en) | 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake | |
| JPWO2023135237A5 (https=) |